MedTrace Logo

HEAD Injury Serum Markers and Multi-modalities for Assessing Response to Trauma

NCT04423198 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-08-04

No results posted yet for this study

Summary

The goal of HeadSMART II (HEAD injury Serum markers and Multi-modalities for Assessing Response to Trauma II) is to develop an In-Vitro Diagnostic, the BRAINBox TBI test, to aid in the diagnosis and prognosis of patients with mild traumatic brain injury, by incorporating blood biomarkers, clinical assessments, and tools to measure associated neurocognitive impairments.

Conditions

  • Mild Traumatic Brain Injury

Interventions

BEHAVIORAL

Cognitive Assessment

Self administered cognitive battery

BEHAVIORAL

Patient Reported Neurological Outcome Assessments

Standard neurocognitive and neuropsychological tests

PROCEDURE

Blood Draw

Specimen collection of whole blood, serum, RNA

Sponsors & Collaborators

  • BRAINBox Solutions Inc

    lead INDUSTRY

Principal Investigators

  • Frank Peacock, MD · Baylor College of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04423198 on ClinicalTrials.gov